Sagimet Biosciences Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-24.5M | $-24.5M | — | $1.9M |
| FY2023 | $-23.8M | $-23.8M | — | $5.0M |
| FY2024 | $-42.4M | $-42.4M | — | $5.3M |
| FY2025 | $-45.7M | $-45.7M | — | $6.4M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-24.5M | $-24.5M | — | $1.9M |
| FY2023 | $-23.8M | $-23.8M | — | $5.0M |
| FY2024 | $-42.4M | $-42.4M | — | $5.3M |
| FY2025 | $-45.7M | $-45.7M | — | $6.4M |